Embecta Corp.: Form 10-Q for the period ended Jun 30, 2026
Filed with the SEC on Aug 7, 2026 and accepted by EDGAR at Aug 7, 2026, 14:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-04-01 to 2026-06-30 | $271.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-10-01 to 2026-06-30 | $754.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-04-01 to 2026-06-30 | $118.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-10-01 to 2026-06-30 | $311.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-04-01 to 2026-06-30 | $153.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-10-01 to 2026-06-30 | $442.8m | us-gaap:GrossProfit |
| Research and development | 3 months2026-04-01 to 2026-06-30 | $5.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-10-01 to 2026-06-30 | $15.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-04-01 to 2026-06-30 | $78.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-10-01 to 2026-06-30 | $232.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-04-01 to 2026-06-30 | $48.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-10-01 to 2026-06-30 | $167.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2026-04-01 to 2026-06-30 | $6.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-10-01 to 2026-06-30 | $34.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-04-01 to 2026-06-30 | $21.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-10-01 to 2026-06-30 | $61.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-04-01 to 2026-06-30 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-10-01 to 2026-06-30 | $1.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-04-01 to 2026-06-30 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-10-01 to 2026-06-30 | $1.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-04-01 to 2026-06-30 | 58,512,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-10-01 to 2026-06-30 | 59,580,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-10-01 to 2026-06-30 | $90.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-10-01 to 2026-06-30 | $2.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2025-10-01 to 2026-06-30 | $18.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2025-10-01 to 2026-06-30 | $8.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-06-30 | $214.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-06-30 | $705.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-06-30 | $1.27bn | us-gaap:Assets |
| Current liabilities | At period end2026-06-30 | $419.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2026-06-30 | $1.32bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2026-06-30 | $139.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2026-06-30 | −$612.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001872789-26-000033. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.